To investigate the physiopathology of ejaculatory disorders (EjD) and discriminate between retrograde ejaculation (REj) and anejaculation (AEj) induced by α1A-blockers, through the association between the mean post-orgasm seminal vesicle volume and the presence of sperm in mid-stream urine, in patients with moderate-to-severe lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement.
Pavone, C., Abrate, A., Li Muli, P., Guzzardo, C., Guarneri, A.G., Dioguardi, S., et al. (2020). Can we clinically distinguish anejaculation from retrograde ejaculation in patients on α1A-blockers therapy for lower urinary tract symptoms?. UROLOGY, 139, 129-133 [10.1016/j.urology.2020.01.027].
Can we clinically distinguish anejaculation from retrograde ejaculation in patients on α1A-blockers therapy for lower urinary tract symptoms?
Pavone, Carlo
Supervision
;Abrate, Alberto;Guzzardo, Calogero;Guarneri, Alessio Giuseppe;Dioguardi, Salvatore;Sanfilippo, Chiara;Vella, Marco;Serretta, Vincenzo;Simonato, Alchiede
2020-01-22
Abstract
To investigate the physiopathology of ejaculatory disorders (EjD) and discriminate between retrograde ejaculation (REj) and anejaculation (AEj) induced by α1A-blockers, through the association between the mean post-orgasm seminal vesicle volume and the presence of sperm in mid-stream urine, in patients with moderate-to-severe lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0090429520301114-main.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
140.23 kB
Formato
Adobe PDF
|
140.23 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.